Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods

Daan van Kruining, Qian Luo, Gerhild van Echten-Deckert, Michelle M. Mielke, Andrew Bowman, Shane Ellis, Tiago Gil Oliveira, Pilar Martinez-Martinez*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)232-244
Number of pages13
JournalAdvanced Drug Delivery Reviews
Volume159
DOIs
Publication statusPublished - 2020

Keywords

  • Sphingolipids
  • Neurodegeneration
  • Neuroinflammation
  • Psychiatric diseases
  • Lipidomics
  • Biomarkers
  • Surrogate markers
  • AMYLOID BETA-PROTEIN
  • SPHINGOSINE KINASE 2
  • MULTIPLE-SCLEROSIS
  • ALZHEIMERS-DISEASE
  • PARKINSONS-DISEASE
  • MASS-SPECTROMETRY
  • PLASMA CERAMIDES
  • GANGLIOSIDE METABOLISM
  • ACID SPHINGOMYELINASE
  • HUNTINGTONS-DISEASE

Cite this